ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,224.62
-0.36%
Dow Jones
38,852.86
-0.55%
Gold vs US Dollar
2,345.155
-0.60%
Brent Oil
84.585
0.31%
Bitcoin
67,916.91
-0.55%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Kali Inc (CE) (KALY)

  7. Kali Inc (CE) (KALY) News

Kali (CE) (KALY)

Kali Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:KALY
DateTimeSourceHeadlineSymbolCompany
06/05/202118:17InvestorsHub NewsWirePAOG 2021 CBD Nutraceuticals Sales Plan Preview This Friday To Include ALKM and USMJ Partnership HighlightsUSOTC:KALYKali Inc (CE)
05/05/202118:30InvestorsHub NewsWirePAOG 2021 CBD Nutraceuticals Rollout Preview This Friday To Include ALKM and USMJ Partnership UpdatesUSOTC:KALYKali Inc (CE)
03/05/202120:22InvestorsHub NewsWirePAOG 2021 CBD Nutraceutical Sales Rollout Plan Presentation Scheduled This FridayUSOTC:KALYKali Inc (CE)
13/04/202114:35InvestorsHub NewsWirePAOG Announces Negotiations To Acquire Partnership Interest In Patented Cannabis Extraction TechnologyUSOTC:KALYKali Inc (CE)
12/04/202113:43InvestorsHub NewsWirePAOG Signals BUY - CBD Pharma Development Backed US PatentUSOTC:KALYKali Inc (CE)
08/04/202113:57InvestorsHub NewsWirePAOG U.S. Patent Backed CBD Pharmaceutical Development Remains On TrackUSOTC:KALYKali Inc (CE)
16/03/202113:17InvestorsHub NewsWirePAOG Targets September 2021 To Introduce CBD Nutraceuticals To Market Co-Packed By ALKM and Marketed Through USMJUSOTC:KALYKali Inc (CE)
10/03/202118:42InvestorsHub NewsWirePAOG Announces Save The Date For CBD Nutraceuticals Expansion UpdateUSOTC:KALYKali Inc (CE)
08/03/202116:32InvestorsHub NewsWirePAOG Announces RELAX-RX Nutraceutical For $18 Billion Anxiety And Depression Treatment MarketUSOTC:KALYKali Inc (CE)
03/02/202113:37InvestorsHub Cannabis NewsWirePAOG Announces $50,000 Estimated Q4 2020 Revenue From Cannabis Cultivation SubsidiaryUSOTC:KALYKali Inc (CE)
03/02/202113:37InvestorsHub NewsWirePAOG Announces $50,000 Estimated Q4 2020 Revenue From Cannabis Cultivation SubsidiaryUSOTC:KALYKali Inc (CE)
27/01/202114:18InvestorsHub Cannabis NewsWirePAOG Takes Next Step To Produce Cannabis NutraceuticalsUSOTC:KALYKali Inc (CE)
27/01/202114:18InvestorsHub NewsWirePAOG Takes Next Step To Produce Cannabis NutraceuticalsUSOTC:KALYKali Inc (CE)
20/01/202114:52InvestorsHub Cannabis NewsWirePURA In Partnership With PAOG and ALKM Prepare For Biden Bull Cannabis MarketUSOTC:KALYKali Inc (CE)
20/01/202114:52InvestorsHub NewsWirePURA In Partnership With PAOG and ALKM Prepare For Biden Bull Cannabis MarketUSOTC:KALYKali Inc (CE)
13/01/202116:22InvestorsHub NewsWirePAOG Dividend Update Included In 2021 Cannabis Biopharmaceutical Strategic Update TomorrowUSOTC:KALYKali Inc (CE)
11/01/202116:10InvestorsHub NewsWirePAOG Cannabis Pharmaceutical and Nutraceutical 2021 Strategy Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2...USOTC:KALYKali Inc (CE)
22/12/202016:57InvestorsHub NewsWirePAOG Expects To Report First Post Acquisition Revenue In Q4 2020USOTC:KALYKali Inc (CE)
18/12/202014:10InvestorsHub NewsWirePAOG Targets First Revenue From $12.7 Billion Market Selling CBD COPD Nutraceutical Care Product LineUSOTC:KALYKali Inc (CE)
18/12/202014:10InvestorsHub Cannabis NewsWirePAOG Targets First Revenue From $12.7 Billion Market Selling CBD COPD Nutraceutical Care Product LineUSOTC:KALYKali Inc (CE)
17/12/202017:34InvestorsHub Cannabis NewsWirePAOG Announces Puerto Rico Consortium For Clinical Investigation Engagement To Advance CBD COPD Nutraceutical Care SolutionUSOTC:KALYKali Inc (CE)
17/12/202017:34InvestorsHub NewsWirePAOG Announces Puerto Rico Consortium For Clinical Investigation Engagement To Advance CBD COPD Nutraceutical Care SolutionUSOTC:KALYKali Inc (CE)
17/11/202014:41InvestorsHub NewsWirePAOG Publishes Q3 RPT Including PURA And KALY Acquisitions - Now One Key Step Closer To Dividend DistributionUSOTC:KALYKali Inc (CE)
23/10/202015:24InvestorsHub NewsWirePAOG Signs Clinical Research Organization (CRO) to Advance Respiratory Cannabis Treatment Through Regulatory ApprovalUSOTC:KALYKali Inc (CE)
21/10/202014:59InvestorsHub NewsWirePAOG Cannabis Drug Company Trends Bullish - $0.01 Breakout On Horizon?USOTC:KALYKali Inc (CE)
16/10/202018:46InvestorsHub NewsWirePAOG and PURA Announce Free Hemp Seed Giveaway To Promote CBD and Hemp AwarenessUSOTC:KALYKali Inc (CE)
15/10/202014:44InvestorsHub NewsWirePAOG Releases Cannabis Drug Development UpdateUSOTC:KALYKali Inc (CE)
05/10/202016:24InvestorsHub Cannabis NewsWirePAOG Taps Canopy Growth And Altria ResourceUSOTC:KALYKali Inc (CE)
05/10/202016:24InvestorsHub NewsWirePAOG Taps Canopy Growth And Altria ResourceUSOTC:KALYKali Inc (CE)
30/09/202015:20InvestorsHub NewsWirePAOG Cannabis Pharmaceutical Research Initiative Gains New TractionUSOTC:KALYKali Inc (CE)
 Showing the most relevant articles for your search:USOTC:KALY

Your Recent History

LSE
KRS
Keras Resources
GATE
DFNDUSDT
dFund
COIN
NDCCCUST
NASDAC Crypto Coin
EU
BANI
Banimmo
NASDAQ
TYHT
Shineco
UNSW
NEXTETH
NEXT
EU
CRAP
Credit Agricole Alpes Pr...
NYSE
NTB
Bank of NT Butterfield a...
NASDAQ
MFIN
Medallion Financial
BSTP
EUROCEUR
Euro Coin
LSE
SKW
USOTC
BODYW
Beachbody (PK)
NASDAQ
TCX
Tucows
EU
ALNLF
Neolife
BIT
YSFT
Qannas Investment
BIT
P1IXE8
BNP Paribas Issuance
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved